产品封面图
文献支持

毛蕊花糖苷|Acteoside| 61276-17-3

收藏
  • ¥450 - 2500
  • 仕诺达
  • SND-001
  • 安徽
  • 2025年08月12日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 库存

      999

    • 英文名

      Acteoside

    • CAS号

      61276-17-3

    • 保质期

      详见产品说明

    • 供应商

      仕诺达生物

    • 保存条件

      -20度

    • 规格

      20mg;分析标准品98% (多规格选择)/200mg;分析标准品

    规格:20mg;分析标准品98% (多规格选择)产品价格:¥450.0
    规格:200mg;分析标准品产品价格:¥2500.0

    产品细节图片1

    中文名毛蕊花糖苷
    英文名acteoside
    别名阿克苷
    麦角甾苷
    毛蕊花苷
    毛蕊花糖苷
    类叶升麻苷
    麦角甾苷(毛蕊花糖苷)
    麦角甾苷, 来源于肉苁蓉
    类叶升麻苷,毛蕊花糖苷(标准品)
    毛蕊花糖苷(麦角甾苷,阿克苷,类叶升麻苷)
    英文别名Acetoside
    acteoside
    verbascoside
    Verbascoside
    VERBASCOSIDE WITH HPLC
    3,4-Dihydroxyphenethyl alcohol acteoside
    Extract from Verbena minutiflora (B864379)
    glucopyranoside,2-(3,4-dihydroxyphenyl)ethyl3-o-(6-deoxy-alpha-l-mannopyranos
    2-(3,4-dihydroxyphenyl)ethyl 3-O-(6-deoxyhexopyranosyl)-4-O-[3-(3,4-dihydroxyphenyl)acryloyl]hexopyranoside
    2-(3,4-Dihydroxyphenyl)ethyl 3-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside 4-[(E)-3-(3,4-dihydroxyphenyl)propenoate]
    2-(3,4-dihydroxyphenyl)ethyl 3-O-(6-deoxy-alpha-L-mannopyranosyl)-4-O-[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-beta-D-glucopyranoside
    [(2R,3R,4R,5R,6R)-6-[2-(3,4-Dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
    CAS61276-17-3
    化学式C29H36O15
    分子量624.59
    InChIInChI=1/C29H36O15/c1-13-22(36)23(37)24(38)29(41-13)44-27-25(39)28(40-9-8-15-3-6-17(32)19(34)11-15)42-20(12-30)26(27)43-21(35)7-4-14-2-5-16(31)18(33)10-14/h2-7,10-11,13,20,22-34,36-39H,8-9,12H2,1H3/b7-4+/t13-,20+,22-,23+,24+,25+,26+,27+,28+,29-/m0/s1
    InChIKeyFBSKJMQYURKNSU-ZLSOWSIRSA-N
    密度1.60±0.1 g/cm3(Predicted)
    熔点232℃
    沸点908.8±65.0 °C(Predicted)
    比旋光度(c, 1.15 in MeOH)-84.9
    闪点294.7°C
    蒸汽压0mmHg at 25°C
    溶解度DMSO (微溶),乙酸乙酯 (非常微溶),甲醇 (微溶)
    折射率1.689
    酸度系数9.31±0.10(Predicted)
    存储条件Sealed in dry,Room Temperature
    稳定性吸湿性
    外观固体
    颜色White to Pale Yellow
    物化性质类白色或淡黄色结晶粉末,溶于甲醇,来源于大芸(硬质肉苁蓉发黑含量最高0.47%)大叶紫珠、车前子、地黄、肉苁蓉、紫竹叶。
    MDL号MFCD00221751
    体外研究Verbascoside acts as an ATP-competitive inhibitor of PKC, with an IC 50 of 25 µM. Verbascoside shows K i s of 22 and 28 µM with respect to ATP and histone, respectively. Verbascoside has potent antitumor activity against L-1210 cells, with an IC 50 of 13 µM. Verbascoside (5, 10 µM) suppresses 2,4-dinitrochlorobenzene (DNCB)-induced T cell costimulatory factors CD86 and CD54, proinflammatory cytokines, and NFκB pathway activation in THP-1 cells.
    体内研究Verbascoside (1%) reduces the overall scratching behavior incidence as well as the severity of the skin lesions in 2,4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis (AD) mice model. Verbascoside also blocks DNCB-induced expression of proinflammatory cytokine TNF-α, IL-6, and IL-4 mRNA in skin lesions. Verbascoside (50, 100 mg/kg, i.p.) does not modify chronic constriction injury (CCI)-induced cold allodynia. Verbascoside (200 mg/kg, i.p.) decreases hyper-sensitivity to cold stimulus, actone, on day 3 in rats. Verbascoside also significantly reduces behavioral changes associated with neuropathy. Moreover, Verbascoside decreases Bax and increases Bcl-2 on day 3.

    计算化学数据:

    • 分子量:624.58714g/mol
    •  
    • 化合物是否规范:True
    •  
    • 疏水参数计算参考值(XLogP3-AA):-0.5
    •  
    • 准确质量:624.20542044
    •  
    • 同位素质量:624.20542044
    •  
    • 复杂度:936
    •  
    • 可旋转化学键数量:11
    •  
    • 氢键供体数量:9
    •  
    • 氢键受体计数:15
    •  
    • 拓扑极表面积:245
    •  
    • 重原子数量:44
    •  
    • 确定原子立构中心数量:10
    •  
    • 不确定原子立构中心数量:0
    •  
    • 确定化学键立构中心数量:1
    •  
    • 不确定化学键立构中心数量:0
    •  
    • 同位素原子计数:0
    •  
    • 共价键单元数量:1
    •  
    • CACTVS Substructure Key Fingerprint:AAADcfB4PAAAAAAAAAAAAAAAAAAAAAAAAAA0aIEAAAAAAAABQAAAGgAACAAADBSwmAMyDoAABgCIAiDSCAACAAAgIAAIiAAGiMgZNiKCMRKicAElwBEPuYfA4LwOIAABAAAAQABAAAIAAACAAAAAAAAAAA==



    ■针对客户购买情况公司有不同的优惠折扣,欢迎咨询订购~
    ■郑重申明:本公司销售所有产品均为实物拍摄,如产品出现质量问题,本公司包一切售后!!!
    ■500元以上包邮,本公司提供正规发票,货到付款,可按科研实验要求定制产品!!!
    ■本公司已与很多高校中科院及研发单位合作并也获得了老师的认可和推荐!!! 

      产品细节图片2

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    1. 李许 何然 王红玉 等. D-半乳糖致衰老大鼠脑内促红细胞生成素表达下调及熟地黄的逆转作用[J]. 中国药学杂志 2016 051(018):1562-1568.
    2. 李婷 许霞 常安琪 刘文静 宋青青 宋月林 屠鹏飞.利用在线加压溶剂提取-超高效液相色谱-离子肼-飞行时间-质谱法直接分析中药草苁蓉的化学成分组[J].色谱 2020 38(05):554-563.
    3. 杨德亮,徐凤,刘秀,张闯,吴明根.地黄耐百枯的有效成分分析[J].江苏农业科学,2014,42(01):100-102.
    4. 奚亚亚, 刁家葳, 张学兰,等. 女贞子中4种成分在大鼠血浆中的药动学行为[J]. 中成药, 2018, v.40(08):59-64.
    5. 徐保鑫, 李转梅, 张学兰,等. 女贞子中橄榄苦苷与羟基酪醇在大鼠血浆中的药动学差异[J]. 中成药, 2017, 39(007):1387-1390.
    6. 于福来, 吴丽芬, 庞玉新,等. 海南裸花紫珠中毛蕊花糖苷和木犀草苷含量分析[J]. 中国现代中药, 2016, 18(008):996-1000.
    7. 丁艳霞,王晓琴,张英.基于高效液相色谱的肉苁蓉属药材6个主要苯乙醇苷类成分的含量测定[J].时珍国医国药,2020,31(04):813-816.
    8. 陆春红, 许惠琴, 刘凯,等. 生地环烯醚萜苷类成分对AGEs损伤HUVEC的保护作用[J]. 南京中医药大学学报, 2015, 31(001):55-59.
    9. 蒙雄裕, 徐良, 李华强,等. 用RP-HPLC法测定天目地黄中梓醇和毛蕊花糖苷的含量[J]. 药学服务与研究, 2015, 15(004):273-276.
    10. 田湾湾, 钟琳瑛, 张琦,等. 车前子酒炙工艺优选及其不同炮制品对比研究[J]. 天津中医药, 2020, v.37(02):106-112.
    11. 刘鑫, 赫一鸣, 蔡广知,等. 多指标综合评分优选炒车前子工艺研究[J]. 辽宁中医药大学学报, 2018, 020(010):78-81.
    12. 姜秋, 蒋海强, 李慧芬,等. 女贞子酒蒸过程中5种苯乙醇类成分的变化规律[J]. 中国实验方剂学杂志, 2014, 20(16):60-63.
    13. 谭湘杰, 于福来, 庞玉新,等. 海南裸花紫珠药材中7种成分含量分析[J]. 中国现代中药, 2018, 20(002):173-178.
    14. 黄梅, 于福来, 陈振夏,等. 土壤因子对裸花紫珠有效成分含量的影响研究[J]. 中国药房, 2018(1):2095-2099.
    15. 任永申, 邓鑫, 雷蕾,等. 基于抑菌效应成分指纹谱的黄芩质量评价研究[J]. 药学学报, 2019, 054(012):2155-2161.
    16. 陶玉菡,许惠琴,李莉,农伟虎,李伟.生地、山茱萸抑制和清除糖基化产物的效应成分研究[J].中药药理与临床,2013,29(04):30-33.
    17. 宋晓芳 范宝磊 曾祥玲 李婷婷 史玉敏 邹晶晶 杨洁 陈洪国.HPLC-MS/MS法同时测定不同桂花品种中7个多酚类活性成分的含量[J].药物分析杂志 2019 39(10):1811-1820.
    18. 朱晓富,邓才富,潭秋生,杨丹,卢圣鄂,任风鸣.渝产玄参不同“发汗”天数质量评价[J].中药与临床,2020,11(05):8-10.
    19. 余娜,唐林,谢壮鑫,周厚元,唐皓,李顺祥,朱克俭.臭牡丹不同提取物的抗肿瘤活性筛选及其对裸鼠移植瘤中EMT相关蛋白的影响[J].中药药理与临床,2020,36(04):124-131.
    20. Chen, Xue, et al. "Dendrobium officinalis six nostrum ameliorates urate under-excretion and protects renal dysfunction in lipid emulsion-induced hyperuricemic rats." Biomedicine & Pharmacotherapy 132 (2020): 110765
    21. Liao, Xiaoyan, Yuan Hong, and Zilin Chen. "Identification and quantification of the bioactive components in Osmanthus fragrans roots by HPLC-MS/MS." Journal of pharmaceutical analysis 11.3 (2021): 299-307.
    22. Deng, Junlin, et al. "Comparative evaluation of maceration and ultrasonic-assisted extraction of phenolic compounds from fresh olives." Ultrasonics Sonochemistry 37 (2017): 328-334
    23. Deng, Rui, et al. "Identification of poliumoside metabolites in rat feces by high performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry." Journal of Chromatography B 969 (2014): 285-296.
    24. Yang, Ruocong, et al. "Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): in silico and experimental study." Pharmacological research 157 (2020): 104820.h
    25. Wang, Wei, Dan-Dan Tian, and Zhang-Jin Zhang. "In Vitro Effects of Concomitant Use of Herbal Preparations on Cytochrome P450s Involved in Clozapine Metabolism." Molecules 21.5 (2016): 597
    26. [IF=6.023] Maiquan Li et al."eoside protects against 6-OHDA-induced dopaminergic neuron damage via Nrf2-ARE signaling pathway."Food Chem Toxicol. 2018 Sep;119:6
    27. [IF=5.279] Yirong Jiang et al."Phenylethanoid Glycoside Profiles and Antioxidant Activities of Osmanthus fragrans Lour. Flowers by UPLC/PDA/MS and Simulated Digestion Model."J Agr Food Chem. 2016;64(12):2459–2466
    28. [IF=5.279] Xiaoyan Liao et al."Identification and Quantitation of the Bioactive Components in Osmanthus fragrans Fruits by HPLC-ESI-MS/MS."J Agr Food Chem. 2018;66(1):359–367
    29. [IF=4.556] Maiquan Li et al."Neuroprotective Effects of Four Phenylethanoid Glycosides on H2O2-Induced Apoptosis on PC12 Cells via the Nrf2/ARE Pathway."Int J Mol Sci. 2018 Apr;19(4):1135
    30. [IF=4.411] Wei Wang et al."In Vitro Effects of Concomitant Use of Herbal Preparations on Cytochrome P450s Involved in Clozapine Metabolism."Molecules. 2016 May;21(5):597
    31. [IF=4.411] Dan-Dan Tian et al."Pharmacokinetic Evaluation of Clozapine in Concomitant Use of Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, or Fructus Gardeniae in Rats."Molecules. 2016 Jun;21(6):696
    32. [IF=3.205] Rui Deng et al."Identification of poliumoside metabolites in rat feces by high performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry."J Chromatogr B. 2014 Oct;969:285
    33. [IF=2.629] Zhang Ying et al."The Difference of Chemical Components and Biological Activities of the Raw Products slices and the Wine Steam-Processed Product from Cistanche deserticola."Evid-Based Compl Alt. 2019;2019:2167947
    34. [IF=6.986] Qingqing Song et al."Retention Time and Optimal Collision Energy Advance Structural Annotation Relied on LC–MS/MS: An Application in Metabolite Identification of an Antidementia Agent Namely Echinacoside."Anal Chem. 2019;91(23):15040–15048
    35. [IF=6.558] Qingqing Song et al."Binary code, a flexible tool for diagnostic metabolite sequencing of medicinal plants."Anal Chim Acta. 2019 Dec;1088:89
    36. [IF=6.529] Xue Chen et al."Dendrobium officinalis six nostrum ameliorates urate under-excretion and protects renal dysfunction in lipid emulsion-induced hyperuricemic rats."Biomed Pharmacother. 2020 Dec;132:110765
    37. [IF=5.893] Ruocong Yang et al."Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): In silico and experimental study."Pharmacol Res. 2020 Jul;157:104820
    38. [IF=5.455] Zhang Xian et al."Neurobehavioral alternations of the female offspring born to polycystic ovary syndrome model rats administered by Chinese herbal medicine."Chin Med-Uk. 2021 Dec;16(1):1-19
    39. [IF=4.769] Xiaoyan Liao et al."Identification and quantification of the bioactive components in Osmanthus fragrans roots by HPLC-MS/MS."J Pharm Anal. 2021 Jun;11:299
    40. [IF=4.36] Chenglin Song et al."Deciphering the mechanism of Fang-Ji-Di-Huang-Decoction in ameliorating psoriasis-like skin inflammation via the inhibition of IL-23/Th17 cell axis."J Ethnopharmacol. 2021 Dec;281:114571
    41. [IF=4.183] Wan Gong et al."Rehmannia glutinosa Libosch Extracts Prevent Bone Loss and Architectural Deterioration and Enhance Osteoblastic Bone Formation by Regulating the IGF-1/PI3K/mTOR Pathway in Streptozotocin-Induced Diabetic Rats."Int J Mol Sci. 2019 Jan;20(16
    42. [IF=4.142] Lei Huibo et al."Comprehensive profiling of the chemical components and potential markers in raw and processed Cistanche tubulosa by combining ultra-high-performance liquid chromatography coupled with tandem mass spectrometry and MS/MS-based molecular ne
    43. [IF=4.142] Wang Chenxi et al."Systematic quality evaluation of Peiyuan Tongnao capsule by offline two-dimensional liquid chromatography/quadrupole-Orbitrap mass spectrometry and adjusted parallel reaction monitoring of quality markers."Anal Bioanal Chem. 2019 Nov;4
    44. [IF=3.935] Yong-Sheng Wu et al."Chemical profiling of Callicarpa nudiflora and its effective compounds identification by compound-target network analysis."J Pharmaceut Biomed. 2020 Apr;182:113110
    45. [IF=3.69] Qixin Wang et al."Phenylethanol glycosides from Cistanche tubulosa improved reproductive dysfunction by regulating testicular steroids through CYP450-3β-HSD pathway."J Ethnopharmacol. 2020 Apr;251:112500
    46. [IF=3.279] Pengfei Yuan et al."Cistanche tubulosa Phenylethanoid Glycosides Induce Apoptosis of Hepatocellular Carcinoma Cells by Mitochondria-Dependent and MAPK Pathways and Enhance Antitumor Effect through Combination with Cisplatin:."Integr Cancer Ther. 2021;():
    47. [IF=1.902] Chenxi Wang et al."Multiple component-pharmacokinetic studies on 10 bioactive constituents of Peiyuan Tongnao capsule using parallel reaction monitoring mode."Biomed Chromatogr. 2021 Oct;35(10):e5153
    48. [IF=3.645] Shuo Gu et al."Develop a stepwise integrated method to screen biomarkers of Baihe-Dihuang Tang on the treatment of depression in rats applying with composition screened, untargeted, and targeted metabolomics analysis."Journal Of Separation Science. 2022 M
    49. [IF=4.508] Chunying Li et al."A novel approach for echinacoside and acteoside extraction from Cistanche deserticola Y. C. Ma using an aqueous system containing ionic liquid surfactants."Sustain Chem Pharm. 2022 May;26:100644
    50. [IF=1.134] Ting-Ting ZHANG et al."Construction of ERGO film modified electrode and its combination with HPLC in determination of five active components in Osmanthus fragrans fruits."CHINESE JOURNAL OF ANALYTICAL CHEMISTRY. 2022 Jul;50:100109

    相关实验
    • 17-酮甾类(酮类固醇) 17-ketosteroid,17 oxosteroid

         甾类骨架上第 17位碳原子上的氧基的化合物之总称,缩写 17KS。在生物体内,是由 17位羟基的酶促氧化和 C17 -C20 键切断生成的。在尿中含有来自副肾皮质的去氢表雄酮及其硫酸酯,睾丸酮的代谢物雄酮和表雄酮等。雌酮也以 17-酮甾类的形态存在着。因为副肾皮质和卵巢肿瘤患者的尿中的排出量很高,所以可作为临床的诊断指标。又因 17-酮甾类在碱性间 -硝基苯溶液中呈紫色,所以可进行定量测定。  

    • 17-β-雌二醇 (o)estradiol-17β

        C18 H24 O2 雌甾 -1, 3, 5( 10) -三烯 -3, 17-二醇。系代表性的性激素,可用卵巢、胎盘等制备,在卵泡液、胎盘、妊娠马尿中均可检出。进入子宫上皮细胞后,与性激素受体形成复合体进入细胞核,从而促进新的蛋白质合成,具有引起细胞增殖的作用。此外,能影响未成熟或切除卵巢的大鼠或小鼠的阴道分泌物,使呈现由角化细胞组成的显微镜象,所以也用作生物试验。在生物体内,在 17β -羟甾类脱氢酶的作用下氧化成为雌酮。 17α -羟甾体性激素的作用弱。作为女性

    • 甾类(化合物)17α-羟化酶 steroid 17α-hy- droxylase,s eroid 17α-monooxygeoase

        甾类(化合物)17α-羟化酶 steroid 17α-hy- droxylase,s eroid 17α-monooxygeoase 存在于睾丸、肾上腺的微粒体部分。是一种在甾类分子的17α位置上引入羟基的酶。EC1、14、99、9。需要有分子态氧和NADPH存在,与P-450有关。例如将黄体酮和孕(甾)烯醇酮各自成为17α-羟基黄体酮和17α-羟基孕烯醇酮。在鼠的肾上腺中不存在此酶。    

    图标技术资料

    资料下载:

    1.png 附 (下载 0 次)

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    上海远慕生物科技有限公司
    2025年07月12日询价
    询价
    上海古朵生物科技有限公司
    2025年07月12日询价
    ¥540
    北京索莱宝科技有限公司
    2025年07月15日询价
    ¥250
    上海沪震实业有限公司
    2025年07月14日询价
    ¥50
    四川省维克奇生物科技有限公司
    2026年01月11日询价
    文献支持
    毛蕊花糖苷|Acteoside| 61276-17-3
    ¥450 - 2500